Therapy Director
Sirtex
Therapy Director
Sirtex
Targets liver tumors with radioembolization beads
The Therapy Director is the organizational lead for Market Development and Market Penetration, being a main interface between Sirtex and its customers
Candidates must already live and be legally authorized to work in Japan without visa sponsorship, and have the required experience listed below
SCOPE:
PRIMARY RESPONSIBILITIES:
All your information will be kept confidential according to EEO guidelines.
Do you want to be part of something bigger? A team whose impact stretches across the globe making a real difference to the quality of people’s lives. Sirtex recognizes that well-being, financial health, and work-life balance are crucial for our employees to achieve personal success.
Sirtex offers qualified candidates:
Diversity drives innovation; inclusion fosters belonging, growth and success. Sirtex believes that it takes multiple perspectives and voices to create a culture and workplace which fosters engagement, teamwork, and employee satisfaction to perform our best and deliver on commitments. We are dedicated to fostering an environment where all employees feel valued, included, and can share their ideas so that we can exceed even our own expectations.
Sirtex is An Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status, age or any other characteristic protected under applicable law. Sirtex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Sirtex develops liver-directed cancer therapy using SIR-Spheres Y-90 resin microspheres to treat inoperable liver tumors through selective internal radiation therapy (SIRT). The tiny beads are delivered via a catheter into the liver arteries feeding the tumor, where they lodge in small vessels and emit radiation locally to kill cancer cells while minimizing damage to healthy tissue. Its focus on a catheter-based, liver-specific approach with an established regulatory path distinguishes it from external-beam radiation or systemic chemotherapy. The goal is to provide effective, targeted radiation therapy for liver cancer and expand global access to SIRT.
Explore more opportunities at Sirtex